Boehringer Ingelheim Pharmaceuticals, Inc

Ridgefield,  CT 
United States
https://www.boehringer-ingelheim.us/
  • Booth: 12044a

Cancer takes. Takes away time. Takes away loved ones. At Boehringer Ingelheim we are providing new hope for patients by taking cancer on. We are collaborating with the oncology community to deliver scientific breakthroughs to transform the lives of patients. Our primary focus is in lung and gastrointestinal cancers, with the goal of delivering breakthrough, first-in-class treatments that can help win the fight against cancer. Our commitment to innovation has resulted in pioneering treatments for lung cancer and we are advancing a unique pipeline of cancer cell directed agents, immuno-oncology therapies and intelligent combination approaches to help combat many cancers.

Brands: https://www.inoncology.com/sites/default/files/asco21_letscollaborate_banner_1140w_x_250h_0.png


 Press Releases


 Products

  • MDM2-P53 ANTAGONIST
    Don't miss out on new data regarding p53 pathway targeting. Save the date and join in our Poster Discussion available starting on Friday, June 4 at 9 AM (EDT)....

  • TAKING KRAS ON
    Be sure to visit our virtual exhibit and explore Boehringer Ingelheim's growing KRAS portfolio....